1. Home
  2. RBRK vs ILMN Comparison

RBRK vs ILMN Comparison

Compare RBRK & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBRK
  • ILMN
  • Stock Information
  • Founded
  • RBRK 2013
  • ILMN 1998
  • Country
  • RBRK United States
  • ILMN United States
  • Employees
  • RBRK N/A
  • ILMN N/A
  • Industry
  • RBRK
  • ILMN Medical Specialities
  • Sector
  • RBRK
  • ILMN Health Care
  • Exchange
  • RBRK NYSE
  • ILMN Nasdaq
  • Market Cap
  • RBRK 14.2B
  • ILMN 13.1B
  • IPO Year
  • RBRK 2024
  • ILMN 2000
  • Fundamental
  • Price
  • RBRK $85.49
  • ILMN $90.49
  • Analyst Decision
  • RBRK Buy
  • ILMN Buy
  • Analyst Count
  • RBRK 19
  • ILMN 16
  • Target Price
  • RBRK $98.59
  • ILMN $126.38
  • AVG Volume (30 Days)
  • RBRK 4.3M
  • ILMN 2.0M
  • Earning Date
  • RBRK 06-05-2025
  • ILMN 08-05-2025
  • Dividend Yield
  • RBRK N/A
  • ILMN 3.42%
  • EPS Growth
  • RBRK N/A
  • ILMN N/A
  • EPS
  • RBRK N/A
  • ILMN N/A
  • Revenue
  • RBRK $977,710,000.00
  • ILMN $4,337,000,000.00
  • Revenue This Year
  • RBRK $36.37
  • ILMN N/A
  • Revenue Next Year
  • RBRK $24.48
  • ILMN $3.11
  • P/E Ratio
  • RBRK N/A
  • ILMN N/A
  • Revenue Growth
  • RBRK 43.89
  • ILMN N/A
  • 52 Week Low
  • RBRK $28.34
  • ILMN $68.70
  • 52 Week High
  • RBRK $103.00
  • ILMN $156.66
  • Technical
  • Relative Strength Index (RSI)
  • RBRK N/A
  • ILMN 65.11
  • Support Level
  • RBRK N/A
  • ILMN $88.65
  • Resistance Level
  • RBRK N/A
  • ILMN $91.57
  • Average True Range (ATR)
  • RBRK 0.00
  • ILMN 2.68
  • MACD
  • RBRK 0.00
  • ILMN 0.54
  • Stochastic Oscillator
  • RBRK 0.00
  • ILMN 91.55

About RBRK RUBRIK INC

Rubrik Inc is a company that offers data security solutions to organizations ranging from the largest companies world-wide to mid-sized smaller customers. Its platform is architected to help organizations achieve cyber resilience, which encompasses cyber posture and cyber recovery. It enables organizations to confidently accelerate digital transformation and leverage the cloud to realize business agility. Geographically, the company operates in the Americas, EMEA (Europe, the Middle East, and Africa) and APAC (Asia Pacific). It generates maximum revenue from Americas.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: